局限性肾癌患者的腹腔镜下保留肾单位手术治疗作用及安全性分析  

Analysis of the Efficacy and Safety of Laparoscopic Nephron Sparing Surgery in Patients with Localized Renal Cell Carcinoma

作　　者：唐锦护 Tang Jinhu(The 924th Hospital of the PLA Joint Logistics Support Force,Guilin,Guangxi 541002)

机构地区：[1]中国人民解放军联勤保障部队第九二四医院,广西桂林541002

出　　处：《中外健康》2024年第1期28-30,共3页

摘　　要：分析腹腔镜下保留肾单位手术治疗局限性肾癌患者的作用及安全性。选取中国人民解放军联勤保障部队第九二四医院泌尿外科于2022年1月—2023年12月收治局限性肾癌患者80例为观察对象,采取回顾性研究,根据手术方法差异分为对照组(腹腔镜根治性肾切除术)、观察组(腹腔镜保留肾单位肾肿瘤切除术),观察手术指标、肾功能、血红蛋白水平、术后并发症和复发等情况。结果显示,对照组手术耗时、术中出血量较观察组理想(P<0.05),而引流时间、术后禁食时间、总住院时间较对照组短(P<0.05);治疗后观察组血肌酐(Scr)、尿素氮(BUN)、2-微球蛋白(BMG)水平均较对照组低(P<0.05),而血红蛋白水平较对照组高(P<0.05);术后观察组并发症发生率较对照组低(P<0.05);术后两组复发发生率对比差异不显著(P>0.05)。研究发现,局限性肾癌采取腹腔镜保留肾单位肾肿瘤切除术治疗,尽管手术耗时较长、术中出血量较大,但该治疗方式患者术后肾功能恢复较快,降低手术对患者身体营养状态影响,有效预防并发症、复发等。To analyze the role and safety of laparoscopic nephron sparing surgery in the treatment of localized renal cell carcinoma patients.A retrospective study was conducted on 80 patients with localized renal cancer admitted to the Department of Urology of the 924th Hospital of the PLA Joint Logistics Support Force from January 2022 to December 2023.The patients were divided into a control group(laparoscopic radical nephrectomy)and an observation group(laparoscopic nephron sparing nephrectomy)based on differences in surgical methods.Surgical indicators,renal function,hemoglobin levels,postoperative complications,and recurrence were observed.The results showed that the control group had ideal surgical time and intraoperative blood loss compared to the observation group(P<0.05),while the drainage time,postoperative fasting time,and total hospitalization time were shorter than those of the control group(P<0.05);After treatment,the levels of serum creatinine(Scr),urea nitrogen(BUN),and 2-microglobulin(BMG)in the observation group were lower than those in the control group(P<0.05),while the level of hemoglobin was higher than that in the control group(P<0.05);The incidence of complications in the postoperative observation group was lower than that in the control group(P<0.05);There was no significant difference in the recurrence rate between the two groups after surgery(P>0.05).Research has found that laparoscopic nephron sparing nephrectomy is used to treat localized renal cell carcinoma.Although the surgery is time-consuming and causes significant intraoperative bleeding,this treatment method results in faster recovery of kidney function,reduces the impact of surgery on the patient's nutritional status,and effectively prevents complications and recurrence.

关 键 词：局限性肾癌 腹腔镜保留肾单位肾肿瘤切除术 并发症发生率 肾功能 血红蛋白 

分 类 号：R737.11[医药卫生—肿瘤]